Fig. 2. Patient with symptomatic uterine fibroids treated by MRgHIFU.

Representative images are shown for three different time points. A. Uterine fibroid in 37-year-old woman was hypo-intense on pretreatment T2WI. B. Sagittal contrast-enhanced T1WI showed homogeneous enhancement before MRgHIFU. C. Sagittal contrast-enhanced T1WI showed 100% NPV in fibroid immediately after sonication. D. Fibroid volume shrinkage (65% of baseline) with sustained non-perfused area at 6-month follow-up. NPV = non-perfused volume, T1WI = T1-weighted imaging, T2WI = T2-weighted imaging